Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SHE:002603)

Market Cap	23.69B
Revenue (ttm)	8.11B
Net Income (ttm)	148.47M
Shares Out	1.67B
EPS (ttm)	0.09
PE Ratio	159.55
Forward PE	18.08
Dividend	0.30 (2.12%)
Ex-Dividend Date	Jul 19, 2024

Volume	12,123,380
Average Volume	20,352,084
Open	14.56
Previous Close	14.24
Day's Range	14.07 - 14.56
52-Week Range	13.25 - 22.22
Beta	0.27
RSI	37.12
Earnings Date	Apr 29, 2025

About SHE:002603

Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese medicine primarily in China. It offers drugs for respiratory health, cardiovascular disease, diabetes mellitus, oncology, urologic disease, sleep-improving, and anti-aging. The company also provides dietary supplements, health food and drinks, disinfection products, and personal protective equipment, as well as formula granules. Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded in 1992 and is based in Shijiazhuang, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1992
• Employees: 13,958
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002603

Financial Performance

In 2023, SHE:002603's revenue was 10.32 billion, a decrease of -17.67% compared to the previous year's 12.53 billion. Earnings were 1.35 billion, a decrease of -42.76%.